chr21-33241954-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001289125.3(IFNAR2):c.32G>C(p.Arg11Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R11S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001289125.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 45Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNAR2 | ENST00000342136.9 | c.32G>C | p.Arg11Thr | missense_variant | Exon 2 of 9 | 1 | NM_001289125.3 | ENSP00000343957.5 | ||
IFNAR2-IL10RB | ENST00000433395.7 | c.32G>C | p.Arg11Thr | missense_variant | Exon 2 of 13 | 5 | ENSP00000388223.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152224Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000360 AC: 9AN: 250298 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460558Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726612 show subpopulations
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152342Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74506 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.32G>C (p.R11T) alteration is located in exon 2 (coding exon 1) of the IFNAR2 gene. This alteration results from a G to C substitution at nucleotide position 32, causing the arginine (R) at amino acid position 11 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at